Photo: Schlomit, multiple myeloma, Israel
We recognize the incredible burden that cancer places on individuals and the people who care for them. Their stories motivate and inspire us in our mission to develop novel treatment options, expand access to therapies, provide comprehensive patient support resources, and work with patient organizations worldwide to fully understand both patient and caregiver needs.
We’re building on a rich legacy in oncology. With a strong pipeline and renewed commitment to advancing transformative therapies, we aim to improve outcomes and impact the lives of people living with many different types of cancer. Our oncology strategy focuses on high-quality assets across skin, blood, breast, and lung cancers, and centers on four anchor treatments that we believe have the potential to transform patient care.
Inspired by patients worldwide
Above, from left to right: Naomi, breast cancer, Japan; Danielle, multiple myeloma, US; Ron, cutaneous squamous cell carcinoma, US
Research & Development
We’re investing substantially in the next generation of cancer medicines.
When Cancer Grows Old
This multiyear initiative is intended to address the challenges of cancer and aging.
Responsive Innovation in Metastatic Breast Cancer Research
Science & Innovation: Cancer Under Siege
Adjusting to Life with Multiple Myeloma: Bernard’s Story